PROF vs TROW · rev $10.7M vs P/E 12, rev $7.09B
Profound Medical Corp (PROF) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
PROF currently screens at market cap $238.7M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the PROF and TROW stock pages for the full models.
Not investment advice.